Intensive care medicine
-
Intensive care medicine · Nov 2018
Correction to: Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients.
Because of a technical error, the code corresponding to the outcome for the Basir et al. cohort was mis-implemented in the original version of our article. Characteristics of the cohort are in fact the followings.
-
Intensive care medicine · Nov 2018
Impact of a multifaceted prevention program on ventilator-associated pneumonia including selective oropharyngeal decontamination.
We describe the impact of a multifaceted program for decreasing ventilator-associated pneumonia (VAP) after implementing nine preventive measures, including selective oropharyngeal decontamination (SOD). ⋯ Our preventive program produced a sustained decrease in VAP incidence. SOD provides an additive value.
-
Intensive care medicine · Nov 2018
Healthcare-related costs in very elderly intensive care patients.
The long-term outcome of "very old intensive care unit patients" (VOPs; ≥ 80 years) is often disappointing. Little is known about the healthcare costs of these VOPs in comparison to younger ICU patients and the very elderly in the general population not admitted to the ICU. ⋯ VOPs required more healthcare resources in the year before, the year of and the year after ICU admission compared to younger ICU patients and the very elderly control population, except compared to the ICU 65-80 population in the year of ICU admission. Healthcare costs per day alive, however, are substantially higher for VOPs than for all other study groups in all three studied years.
-
Intensive care medicine · Nov 2018
Letter Randomized Controlled TrialPhase 1 safety and pharmacokinetic study on the use of pioglitazone in critically ill patients with sepsis: a randomized clinical trial.
Abstract